Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

  • Oñate, Guadalupe|||0000-0003-2180-2371
  • Bataller, Alex|||0000-0002-6085-2745
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Hoyos Colell, Montserrat|||0000-0002-1911-1734
  • Arnan, Montserrat
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Coll, Rosa|||0000-0003-0560-1254
  • Tormo, Mar|||0000-0001-9622-1649
  • Sampol, Antonia|||0000-0001-7465-6203
  • Escoda, Lourdes|||0000-0003-3288-9716
  • Salamero, Olga|||0000-0003-3237-0025
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Bargay, Joan|||0000-0002-6739-3916
  • Aljarilla, Alba
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
  • Sierra, Jorge|||0000-0002-7966-0356
  • Pratcorona, Marta|||0000-0001-6375-596X
The negative prognostic impact of internal tandem duplication of FLT3 (FLT3- ITD) in patients with acute myeloid leukemia with mutated NPM1 (AML- NPM1) is restricted to those with a higher FLT3 -ITD allelic ratio (FLT3 high ; ≥0.5) and considered negligible in those with a wild-type (FLT3 WT)/low ITD ratio (FLT3 low). Because the comutation of DNMT3A (DNMT3A mut) has been suggested to negatively influence prognosis in AML- NPM1, we analyzed the impact of DNMT3A mut in FLT3 -ITD subsets (absent, low, and high ratios). A total of 164 patients diagnosed with AML- NPM1 included in 2 consecutive CETLAM protocols and with DNMT3A and FLT3 status available were studied. Overall, DNMT3A mut status did not have a prognostic impact, with comparable overall survival (P =.2). Prognostic stratification established by FLT3 -ITD (FLT3 WT = FLT3 low.